| Firm | Analyst |
|---|---|
| BofA Securities | Jason Gerberry |
| Cantor Fitzgerald | Louise Chen |
| Citi Research | Samantha Semenkow |
| Goldman Sachs | Corinne Jenkins |
| Guggenheim | Yatin Suneja |
| HC Wainwright | Douglas Tsao |
| JP Morgan | Brian Cheng |
| Leerink | Tom Smith |
| LifeSci Capital | Sam Slutsky |
| Oppenheimer | Leland Gershell |
| Piper Sandler | Yasmeen Rahimi |
| Raymond James | Danielle Brill |
| Stifel | Alex Thompson |
| Truist | Robyn Karnauskas |
| UBS | Ashwani Verma |
| Wells Fargo | Derek Archila |
| Wolfe | Andy Chen |
Immunovant, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Immunovant, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Immunovant, Inc. or its management. Immunovant, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.